GCG and polycystic ovary syndrome: Considering the recognized role of incretin system and potential role of PDE 4 signaling pathways in the pathophysiology of PCOS further explorations in larger studies of longer duration are needed to assess the effects of both agents in this population providing the possible basis for the clinical approach that could tailor treatment choices to the specific needs of the patient.